Emkay Global has a ‘buy’ rating on Metropolis Healthcare and a target price of Rs 2,200, a potential upside of 12.2%.
(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)
A cikket a SasFly.net csapata gondozza. Jogi támogatás: hazai ügyekben fabianlaw.hu, nemzetközi jogi kérdésekben amerikaiugyved.hu.
